Background: Walnuts (WN) are one of the main causes of tree nut allergies. However, the potential value of component resolved diagnosis (CRD) for WN allergy is controversial.
Introduction
Walnut (WN) is one of the many allergens responsible for cases of tree nut (TN) allergy and can induce fatal allergic reactions. [1] [2] [3] Based on a Korean survey performed in 2008, no individual was documented to be allergic to WN. 4 However, WN imports have quadrupled in the last 10 years, 5 and WN now ranks as the third most common food that induces anaphylaxis in Korean children. 3, 6 Nevertheless, there has been minimal study on WN allergy in very young children to date. [6] [7] [8] [9] A double-blinded, placebo-controlled food challenge (DB-PCFC) is the gold standard to confirm food allergies but is contraindicated in patients with a previous history of anaphylaxis. In fact, WN often induces severe allergic reactions that necessitate close supervision by experienced allergists during DBPCFC. In 2008, Maloney et al. 10 investigated diagnostic decision points (DDPs) for WN, indicating that patients with WN-specific immunoglobulin E (sIgE) levels greater than 18.5 kU/L have a very high probability of experiencing a reaction to WN.
Recombinant technology now allows for the production of components of WN allergen that can be used for component resolved diagnosis (CRD). 11 CRD may be useful to identify the most problematic allergens in patients with specific sensitization patterns and could help to distinguish anaphylaxis from milder symptoms. 7, 12, 13 At present, eight WN allergens have been
Methods

Study population
Based on a retrospective review of medical records, 189 patients aged 12 years or younger who visited the Ajou University Hospital (Suwon, Korea) underwent the ImmunoCAP test (Thermo Fisher Scientific Inc., Uppsala, Sweden) for WN-sIgE levels between May 2010 and May 2015. Among these patients, the parents of 41 patients provided informed consent to participate in additional serological analysis, and serum samples were taken simultaneously and stored at −20°C.
The diagnostic criteria for clinical WN allergy were as follows: 16 1) WN-sIgE ≥ 0.10 kU/L; 2) immediate reaction in the skin, gastrointestinal, or respiratory organs within 2 h of exposure; and 3) repeated experience or met the diagnostic criteria for anaphylaxis. 17 Individuals with WN-sIgE ≥ 0.10 kU/L but who were asymptomatic after consumption were classified as tolerant (T). Moreover, three patients with atopic dermatitis (AD), WN-sIgE < 0.10 kU/L, and who were asymptomatic after exposure were included as the control (C) group (Supplemental Figure S1 ). Urticaria was defined as skin erythema including hives, and angioedema was defined as mucosa swelling with identified and characterized from English walnut (Juglans regia), 14 three of which are available in the ImmunoCAP ISAC system (Thermo Fisher Scientific Inc., Uppsala, Sweden): 2S albumin seed storage protein (Jug r 1; 15-16 kDa), vicilin seed storage protein (Jug r 2; 44 kDa), and non-specific lipid transfer protein (Jug r 3 or LTP; 6 kDa). However, the specific allergens involved in the allergic response to WN were found to differ among patients and were dependent on age, geographic region, and pollinosis. Further, the additional diagnostic value provided by CRD for WN allergy has proven to be controversial. [11] [12] [13] 15 Thus, the aim of this study was to investigate the clinical and immunological characteristics of young Korean children with clinical WN allergy to identify the major allergenic components recognized in this population. Furthermore, we investigated whether additionally performing CRD has greater benefits for diagnosing WN allergy than simply measuring crude WN-sIgE. Drop out (n = 148) due to unmet inclusion criteria, incomplete medical chart, unreachable contact, refusal Children who underwent WN-sIgE testing due to suspected walnut allergy (n = 189) or without hives. We excluded cases limited to the perioral area. Controls were screened for those who were diagnosed with AD but not diagnosed with pollinosis. The study was approved by the institutional review board at Ajou University Medical Center (MED-KSP-12-381).
Microarray
CRD was performed on all patients using the commercially available immune solid-phase allergen chip (ISAC) immunoassay ImmunoCAP ISAC (CRD 112; Thermo Fisher Scientific Inc., Uppsala, Sweden) according to the manufacturer's guidelines and as reported previously. 11 Data are expressed as ISAC standardized units (ISU/L, ISU), and the decision threshold was set at 0.
Statistical analysis
Statistical analyses were performed using R version 3.0.2 software (R Foundation for Statistical Computing, Vienna, Austria). Normality was tested, and P-values for continuous variables were calculated using the Kruskall-Wallis test. Fisher's exact test was performed to compare categorical variables. Pearson correlation analysis was performed to analyze the correlation between WN-sIgE (kU/L) and Jug r 1-sIgE (ISU) concentrations. The best cutoff was found using receiver operation characteristic (ROC) curve analysis, and area under curve values (AUCs) were compared using the Delong test. P < 0.05 was considered statistically significant.
Results
Demographic and clinical characteristics of patients
Among the 41 patients, 32 had WN-sIgE ≥ 0.10 kU/L (0.10-91.3 kU/L) and met the clinical diagnostic criteria for WN allergy. The median age was 28 months, with a range of 5-108 months. Symptoms from exposure included anaphylaxis (Ana, n = 7), angioedema (Ang, n = 10), and urticaria (U, n = 15). Among the 7 patients with Ana, all patients showed skin rash and respiratory symptoms, and none of the patients had digestive, circulatory, or neurologic symptoms. Two patients had other food allergies (pine nut and peanut, respectively). Among the 10 patients with Ang, the youngest was 8 months old, and developed hives and edema after consuming ground walnut mixed in water. Ang patients were significantly younger than the other symptom groups (p < 0.05). Among the 12 patients diagnosed with U, the youngest patient was a 5-monthold breast milk-fed infant who had repeated skin rashes with wheals when the mother consumed WN while breastfeeding.
With regard to other allergic comorbidities, asthma was present in 3 Ana patients, 1 Ang patient, and 1 U patient, while allergic rhinitis was present in 4 Ana patients, 2 Ang patients, and 1 U patient. AD was present in 4 Ana patients, 1 Ang patients, and 8 U patients.
Feeding history was taken from 21 patients. Fourteen (66.7%) patients were exclusively breastfed for the first four months, 7 (50.0%) of whom experienced an allergic reaction to WN on their first exposure.
Further, 7 children had WN-sIgE ≥ 0.10 kU/L (0.42-53.5 kU/L) but did not develop symptoms upon exposure (T). The mean age of these children was 55 months, and 6 of those (85.7%) had an allergy to other foods. The comorbidity rate for other food allergies was significantly higher among T patients (p < 0.05, Supplemental Table S1 , Table 1 Table S1 . Demographic, clinical, and immunological characteristics of the subjects.
Ana, anaphylaxis; Ang, angioedema; U, urticaria; T, tolerant; BF, breastfeeding; MixF, mixed feeding; FF, formula feeding; Ast, asthma; AD, atopic dermatitis, AR, allergic rhinitis; FA, food allergy; PFS, pollen-food syndrome; WN-sIgE, walnut-specific immunoglobulin E; Jug r 1-sIgE, Jug r 1-specific immunoglobulin E; Jug r 2-sIgE, Jug r 2-specific immunoglobulin E; Jug r 3-sIgE, Jug r 3-specific immunoglobulin E Ana, anaphylaxis; Ang, angioedema; U, urticaria; T, tolerant; BF, breastfeeding; MixF, mixed feeding; FF, formula feeding; Ast, asthma; AD, atopic dermatitis, AR, allergic rhinitis; FA, food allergy; PFS, pollen-food syndrome; WN-sIgE, walnut-specific immunoglobulin E; Jug r 1-sIgE, Jug r 1-specific immunoglobulin E; Jug r 2-sIgE, Jug r 2-specific immunoglobulin E; Jug r 3-sIgE, Jug r 3-specific immunoglobulin E 
Immunological characteristics of patients and the additional diagnostic value of Jug r 1
The ImmunoCAP ISAC (CRD 112) assay indicated that 31 of the 32 clinical WN-allergic patients (96.9%) had specific IgE antibodies to Jug r 1 and only 1 (U-9) was positive for Jug r 2-sIgE isolate. The comparison of the immunological features in relation to clinical symptoms showed that the Jug r 1-sIgE concentration varied significantly between the groups (p < 0.05). It was higher in the Ana (12.9 vs 0.8; p < 0.05), Ang (5.8 vs 0.8; p = 0.48), and U (6.4 vs 0.8; p = 0.60) group than in the T group (Figure 1, Table 1 ). In contrast, no statistically significant differences in the WN-sIgE concentration were detected among those groups. In addition, the WN-sIgE concentration of 23 out of 32 (71.9%) clinical WN-allergic children was below DDP level (≤ 18.5 kU/L, Table S1 ).
We further analyzed the ImmunoCAP ISAC results for legumes and TNs in 32 clinically WN-allergic patients. All patients were sensitized to the storage protein of WN, and none was exclusively sensitized to the LTP antigen, Jug r 3. Fifteen patients (46.9%) were co-sensitized to more than one storage protein. The protein with the highest positivity was the soy storage protein Gly m 6 (n = 8, 25.0%), followed by hazel (Cor a 9, n = 7, 21.9%) and peanut (Ara h 2, n = 6, 18.8%; Figure  2 ). Only two patients (37 months and 66 months old) were co-sensitized to PR-10, and both had a history of pollen food syndrome. Cross-reactive carbohydrates (CCD) were negative in all patients. Meanwhile, six patients in the T group (85.7%) were co-sensitized to more than one storage protein. Information on clinical hypersensitivity to other TNs was not fully available for all patients.
A positive, significant correlation between Jug r 1-sIgE and WN-sIgE levels was found (r = 0.468; CI 0.187-0.678, p < 0.05; Figure 3 ). The ROC curves showed that the Jug r 1-sIgE measurement was better than the WN-sIgE measurement in discriminating between clinical WN allergy and WN tolerance in young children (AUC = 0.788, p < 0.05; Figure 4) . be studied further. The T group showed a high rate of other food allergies and had a significantly lower Jug r 1-sIgE concentration. Therefore, WN and wide-ranging TN avoidance guidance must not be given to young children with positive results of serum study only, especially, when their WN-sIgE level is ≥ 0.10 kU/L with a low Jug r 1-sIgE concentration, and they have already been diagnosed with a soybean or peanut allergy. For the purpose of screening sensitization to the other tree nuts, multiplex component-based allergen microarray would be particularly useful for infants with moderate to severe AD, for whom skin tests are practically difficult. Many of our patients were breastfed or on a mixed-fed diet, which may have contributed to the sensitization, but transcutaneous sensitization through AD as well as co-sensitization due to cross-antigenicity are also possible. [18] [19] [20] Additional studies are needed to provide more accurate diet guidance and, despite practical challenges, a definitive diagnosis based on an OFC appears to be crucial before providing avoidance.
This study has some limitations that should be discussed. The major limitation of this study was its retrospective design. Moreover, the study was based on self-reported history of allergic reactions, and the oral food challenge test was not conducted in most of patients. However, the results of this study are noteworthy, considering that no previous studies have been conducted with CRD for very young children. The median age of our subjects was far lower than that in previous studies, and thus, the underlying diseases were considerably different from those in previous studies, which was reflected in the result of the CRD. Moreover, we recruited participants based on real-world data according to the level of exposure and symptoms, and that heavy exposure tended to occur in one event. In contrast, in other studies, participants were gradually exposed to WN by OFC.
In conclusion, measurement of Jug r 1-sIgE on very young patients with suspected WN allergy could be beneficial for diagnosis and severity assessment, because these patients have a higher specific IgE level to this component than WN-tolerant patients and, furthermore, anaphylaxis patients have a significantly higher level than the tolerant patients.
Discussion
To our knowledge, this is the first study to investigate the value of CRD for WN allergy in very young children. Although oral food challenge (OFC) testing remains vital for a definite diagnosis, parents often disagree with OFC using nuts in very young children. Consequently, definitive diagnosis is often delayed, which hinders research progress. However, since we have occasionally treated clinically WN-allergic patients, we aimed to explore the benefit of CRD among such young patients for whom the OFC is practically difficult. Furthermore, we examined co-sensitization profiles of other nuts prior to ingestion.
To date, there have been three studies on CRD for WN allergy in older children. 7, 12, 13 In 2014, a study was conducted on 45 children (mean age: 8 years) in Northern Italy, 13 showing a higher percentage of Ana patients who were positive for Jug r 1-sIgE and Jug r 2-sIgE, when compared with those with mild-moderate WN allergy. In our study, only the Jug r 1-sIgE level was higher in WN-allergic patients than in tolerant patients and this level was significantly higher among patients with anaphylaxis than among patients with WN tolerance, which suggested an association with severity. Our observation that patients with anaphylaxis had higher Jug r 1-sIgE levels may be explained by the fact that it is specific to a storage protein that contributes to the severe systemic response. However, considering the finding of earlier research that Jug r 1-sIgE level was not associated with the severity of allergic reactions, there is a need to examine whether our observation is specific to the age group examined in this study.
In a 2016 British study, 12 although the Jug r 1-sIgE level was significantly higher than that among tolerant children, the AUC value was similar to that for WN-sIgE. A recent Japanese study 6 administered an OFC to 108 children (median age of 6-7 years) and found higher WN-sIgE and Jug r 1-sIgE concentrations among the WN allergy group than among the tolerant group. In contrast to the British and Japanese studies, the WNsIgE concentrations in our study did not discriminate across groups, and the AUC of WN-sIgE was far weaker than that of Jug r 1-sIgE. This difference may be attributable to the fact that the clinical and immunological features of food allergy depend on age and region. Furthermore, in this study, when the DDP of WN-sIgE was set as 18.5 kU/L, 71.9% of clinically allergic patients were falsely predicted as tolerant; thus, clinicians must be aware of this. ImmunoCAP-ISAC is expensive and limited to research purposes in many countries, but the cost of selecting and implementing Jug r 1-sIgE is similar to that of using WNsIgE. Hence, based on our results, among the components of WN, to measure Jug r 1-sIgE for diagnosis would be beneficial and cost-effective in this age group.
It is also noteworthy to consider the history of patients who experienced WN allergies on their first exposure. Based on the experience of a patient (Ang-2) who never ingested WN and did not have AD but had a WN-allergic reaction at 8 months of age with a WN-sIgE level of 30.0 kU/L. In addition, we found that approximately 50% of the patients with clinical WN allergy were already poly-sensitized to numerous allergens other than WN, and the majority of them had no previous history of ingestion. We considered that allergy prevention by early introduction might not only be necessary for moderate-to-severe AD patients and the factors affecting individual variations must Author Contributions 
